A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Cervical Cancer Screening Cascade in Côte d’Ivoire: A Decade of Real-World Program Evaluation According to HIV Status Pancreatic cancer was consistently categorized as a poor-prognosis cancer, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results